Is Polycythemia Vera Genetic Or Hereditary?

Polycythemia vera is a rare blood cancer that causes the bone marrow to produce too many red blood cells. The condition is genetic, but it is almost never inherited from a parent. Most people with polycythemia vera develop the genetic mutation during their lifetime, not from birth, and they cannot pass it on to their children.

What Causes Polycythemia Vera at the Genetic Level?

Polycythemia vera starts with a single mutation in a bone marrow stem cell. Stem cells are the parent cells that mature into red blood cells, white blood cells, and platelets. When that one cell mutates, it multiplies and produces an entire family of blood cells carrying the same error.

More than 95% of people with polycythemia vera have a mutation in a gene called JAK2. The most common version is called JAK2 V617F. A smaller group has a different mutation in the same gene, and a very small number have mutations in a gene called CALR or MPL.

These mutations cause the JAK2 protein to stay permanently active. The protein sends a constant signal telling the bone marrow to make blood cells. The result is too many red blood cells, which thickens the blood and raises the risk of clots.

Is Polycythemia Vera Genetic Or Hereditary?

Polycythemia vera is genetic, but it is not hereditary in the usual sense. A genetic condition means a change in DNA causes the disease. A hereditary condition means that change is passed from parent to child through the egg or sperm.

In polycythemia vera, the mutation is acquired. It happens in a single blood stem cell sometime after conception. It is not present in every cell of the body, and it is not in the egg or sperm. This means a parent with polycythemia vera does not pass the disease to their children.

This is different from inherited conditions like sickle cell disease or hemophilia, where a child is born with the mutation in every cell. Polycythemia vera is a somatic mutation, meaning it occurs in body cells rather than reproductive cells.

Can Polycythemia Vera Run in Families?

Rarely, more than one person in the same family develops polycythemia vera. This happens, but it is uncommon. When it does occur, researchers believe it is not the disease itself that is inherited. Instead, a person may inherit a genetic predisposition that makes their bone marrow slightly more likely to acquire the JAK2 mutation.

Having a family member with polycythemia vera does not mean you will develop it. The absolute risk for a close relative is still very low. Most people with the disease have no family history at all.

There is also a separate condition called familial erythrocytosis. This is a genuinely inherited condition that causes high red blood cell counts. It is caused by different mutations, often in genes that control oxygen sensing in the body. It behaves differently from polycythemia vera and requires different treatment.

What Are the Symptoms of Polycythemia Vera?

Many people with polycythemia vera have no symptoms at first. The condition is often found during a routine blood test. When symptoms do appear, they come from the blood being thicker than normal.

Common symptoms include:

• Headaches and dizziness
• Blurred vision or seeing spots
• Itching, especially after a warm shower
• Fatigue and weakness
• Red or flushed skin, especially on the face
• Burning pain in the hands or feet
• High blood pressure

The most serious risk is blood clots. Thick blood moves more slowly and is more likely to clot. Clots can cause deep vein thrombosis, pulmonary embolism, heart attack, or stroke. This is the main reason polycythemia vera needs treatment even when symptoms are mild.

How Is Polycythemia Vera Diagnosed?

Diagnosis starts with a complete blood count. A high hemoglobin level or a high hematocrit (the proportion of blood made up of red cells) raises suspicion. For most adults, a hematocrit above 48% in women or 49% in men triggers further testing.

The next step is a test for the JAK2 mutation. This is a blood test that looks for the specific genetic change. If the JAK2 mutation is present and red blood cell counts are high, the diagnosis is usually confirmed.

In rare cases, a bone marrow biopsy is needed. This is especially true when JAK2 is negative but the doctor still suspects polycythemia vera. The biopsy shows how active the bone marrow is and helps rule out other conditions.

How Is Polycythemia Vera Treated?

Treatment focuses on lowering the red blood cell count to reduce clot risk. There is no cure, but the disease can be managed well for many years.

The first treatment is usually phlebotomy. A needle is used to remove a unit of blood, similar to donating blood. This lowers the red cell count quickly and safely. Phlebotomy is repeated until the hematocrit is below 45%.

Many people also take low-dose aspirin. Aspirin makes platelets less sticky and reduces the chance of clots. This is standard care for most patients unless there is a reason to avoid aspirin, such as a bleeding risk.

For people at higher risk of clots, or those who need frequent phlebotomy, doctors may prescribe medication. Hydroxyurea is the most common drug used. It suppresses the bone marrow’s blood cell production. Other options include interferon, which can be used in younger patients, and a newer drug called ruxolitinib for cases that do not respond to hydroxyurea.

Can You Prevent Polycythemia Vera?

No, you cannot prevent polycythemia vera. The mutation is random and occurs without a clear cause. There is no lifestyle change, diet, or supplement that has been shown to prevent it.

What you can do is manage the risks once diagnosed. Controlling blood pressure, avoiding smoking, and staying active all reduce cardiovascular risk. These habits do not treat the underlying disease, but they lower the chance of complications.

People with polycythemia vera should also avoid iron supplements unless a doctor recommends them. Iron is needed to make red blood cells, so extra iron can drive production even higher.

What Is the Long-Term Outlook?

With proper treatment, most people with polycythemia vera live for many years. The main goal is preventing blood clots, which are the leading cause of serious complications and death.

A small percentage of people with polycythemia vera eventually develop myelofibrosis, a condition where the bone marrow becomes scarred. An even smaller percentage develop acute myeloid leukemia. These are serious complications, but they are uncommon. Regular monitoring with blood tests helps doctors catch changes early.

Treatment is lifelong. Blood counts are checked regularly, and phlebotomy or medication is adjusted as needed. Many people manage the condition successfully for decades with good quality of life.

Should Family Members Get Tested?

Routine genetic testing for family members is not recommended. Because polycythemia vera is not inherited, a negative test would not tell a family member much about their future risk. A positive JAK2 test in a healthy person is also difficult to interpret and could cause unnecessary anxiety.

Family members should follow standard health screening. A routine complete blood count during an annual physical is reasonable. If a family member develops symptoms like persistent headaches, itching, or unusual bruising, they should mention it to their doctor.

If multiple family members have high red blood cell counts, a doctor might consider familial erythrocytosis. This is the inherited condition, and it requires different genetic testing. But this situation is rare.